Janani S Iyer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Janani S Iyer

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Alimentary Pharmacology & Therapeutics|March 22, 2024

Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver diseaseRohit Loomba, Ginger Clark, Jeff Teckman, et al.

Medrxiv : the Preprint Server for Health Sciences|May 10, 2023

AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trialsJanani S Iyer, Harsha Pokkalla, Charles Biddle-Snead, et al.

Nature Medicine|August 7, 2024

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseasesJanani S Iyer, Dinkar Juyal, Quang Le, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Alimentary Pharmacology & Therapeutics|March 22, 2024

Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver diseaseRohit Loomba, Ginger Clark, Jeff Teckman, et al.

Medrxiv : the Preprint Server for Health Sciences|May 10, 2023

AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trialsJanani S Iyer, Harsha Pokkalla, Charles Biddle-Snead, et al.

Nature Medicine|August 7, 2024

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseasesJanani S Iyer, Dinkar Juyal, Quang Le, et al.

Pageof 2